Awake nasotracheal intubation after adequate topical anaesthesia and constriction of the nasal mucosa is suggested for pregnant patients in whom difficult or impossible direct laryngoscopy is anticipated. * However, there is no published information on the appropriate method of topical nasopharyngeal anaesthesia in the eclamptic patient.
Case report A 3g-year-old, 91 kg gravida 2, para 1 was transferred to University Hospital after treatment in a community hospital emergency room for a grand mal seizure. Systemic arterial blood pressure was 200/130 mnfftg. Urinalysis revealed > 300 mg.dl-' protein. A previously unsuspected pregnancy was shown by ultrasound examination (26.5 weeks gestation). After the diagnosis of eclampsia was made, intravenous magnesium sulfate therapy was begun.
On arrival, the patient was drowsy but responsive to verbal stimuli. Systemic arterial blood pressure was Continuous maternal intra-arterial pressure monitoring was instituted. Intravenous magnesium sulfate therapy was continued. A 0.01 per cent hydralazine IV infusion was titrated to maintain a maternal systemic arterial diastolic blood pressure between 105-i 10 mmHg. Central venous pressure measured via the right internal jugular vein was 7 mmHg. Urinary output was 50-200 nd'hr -t . Lactated Ringer's solution was infused IV at 50 ml.hr-~.
Key words
Six hours later the maternal platelet count had fallen to 38,000.ml i. The decision was made to proceed with Caesarean section because of worsening eclampsia, Examination of the mouth and airway now revealed massive swelling of the tongue which restricted mouth closure. It was not possible to visualize the soft palate.
The patient was taken to the delivery room and positioned supine with left uterine displacement_ Mean maternal systemic arterial blood pressure was 140 mmHg. An IV infusion of 0.1 per cent trimethaphan was started to maintain the maternal systemic arterial diastolic pressure between 95-105 mmHg. Topical nasal anaesthesia was achieved with 4 ml of a 3.0 per cent lidocaine with 0,125 per cent phenylephrine solution (prepared with 3 ml of four per cent l idocaine, 0.5 ml of one per cent phenylephrine and 0.5 ml of normal saline solution) applied to the nasal and nasopharyngeal mucosa with cotton tipped applicators. There were no changes detected in the fetal heart rate. Maternal blood pressure was 150-160/95-100 mmHg. The heart rate was 72 beats-min -l. Central venous pressure was 5 mmHg. The patient was prepared for surgery, An otolaryngologist was immediately available to assist in emergency airway management. Awake fiberoptie (Olympus LFI) nasotracheal intubation with a 6.0 ID Portex tracheal tube was achieved with great difficulty, due to oropharyngeal swelling and glottie oedema. During endoscopy and placement of the endotracheal tube, maternal blood pressure remained at 150-160/95-100 mmHg, with no change in dose requirements of antihypertensive agents. No additional topical anaesthesia was required during the intubation. Genera] anaesthesia was induced immediately after intubation with IV thiamylal 4 mg.kg -t .
Surgery then commenced. Induction to delivery time was five minutes with an uterine incision to delivery time of 60 seconds. A premature female child with Apgar scores of I and 6 at one and five minutes respectively was delivered. Only umbilical venous blood (pH 7.31) was obtained. The trimethaphan infusion was discontinued as intraoperatively the mean maternal systemic arterial blood pressure ranged between 75-100 mmHg. Moderate bleeding from the traumatized nasal mucosa was controlled easily by placement of nasal packing. Surgical haemostasis was judged adequate and the estimated surgical blood loss was 600 ml. The patient was transported to the postanaesthesia care unit intubated but spontaneously ventilating. Postoperatively the swelling of the tongue markedly decreased and the patient was extubated 24 hours after delivery without difficulty. The nasal packing was removed and there was no further bleeding.
Discussion
Awake nasotracheal intubation done after thorough topical anaesthesia can minimize the haemodynamic effects of intubation in sedated nonpregnant patients. 2 However, sedation is best avoided in the pregnant patient due to the possibility of neonatal depression or maternal aspiration. The haemodynamic effects of topical anaesthesia and awake intubation are not well described in pregnant patients and have not been investigated in preeclampticeclamptic patients. Maternal systemic arterial pressures must be controlled in eclampsia to avoid end-organ damage.3 The use of a vasoconstrictor, despite the risk of decreasing uteroptacental per'fusion, was necessary to limit epistaxis in this thrombocytopaenic patient.
A four per cent cocaine solution is widely used for topical anaesthesia in nonpregnant patients. Despite vasoconstriction, cocaine is absorbed from the nasal mucosa. 4 Recent reports though have related nasal cocaine absorption to decreased uterine blood flow. 5-7 The administration of an intravenous 1.4 mg.kg -t dose of cocaine to pregnant ewes has been shown to achieve blood concentrations similar to those seen "after intra-nasal use in humans.5 Within one minute after administration, uterine blood flow has been shown to decrease by 40 per cent. ~ Similar decreases in uterine blood flow occur after 0._5 mg'kg -1 and 1 mg.kg -t intravenous cocaine doses, concomitant with increases in mean arterial blood pres-CANADIAN JOURNAL OF ANAESTHESIA sure. 6 Fetal heart rate was shown to increase 10 to 30 minutes after intravenous administration of 1 and 2 mg.kg-1 cocaine doses to pregnant ewes. 7 We therefore felt that the use of cocaine to obtain anaesthesia and vasoconstriction would risk severe decreases in uteroplacental pedusion in this pregnancy.
The use of aerosolized lldocaine-phenylephrine solutions for nasopharyngeal anaesthesia and vasoconstriction satisfactorily substitutes for four per cent cocaine in nonpregnant patients. 8 There are no differences in heart rate and mean arterial pressure during administration between the two regimens. Mean 'arterial pressure after intubation increases less with the combination of lidocaine-phenylephrine when compared to cocaine or phenylephrine alone (2.3 mmHg decrease vs 6.2 mmHg and 8.5 mmHg increase, respec'dvely). 8 Additionally, there is no difference in the incidence or severity of epistaxis.
Phenylephrine does cause uterine artery vasoconstriction and decreases in uterine blood flow. 9 Although both cocaine and phenylephrine lead to decreased uterine blood flow, we speculate that the l idoeaine-phenylepbrine combination might increase the systemic blood pressure less than cocaine. The evidence in nonpregnant and normotensive patients suggests that the lidocainephenylephrine combination gives important haemodynamic stability, s Thus, we chose the lidocaine-phenylephrine combination easily prepared with four per cent lidocaine, one per cent phcnylcphrine and normal saline solution. There were no changes in fetal heart rate detected after the administration of three per cent lidocaine and 0.125 per cent phenylephrine. The acid-base status of the infant was normal upon delivery.
In conclusion, necessary awake intubation in preeclampsia-eelampsia presents the obstetric anaesthetist with a difficult pharmacologic dilemma. Intubation nlust be performed without the commonly used sedation with adequate topical nasopharyngeal anaesthesia. Prevention of ~evere epistaxis requires vasoconstriction with agents which could lead to decreased uteroplacental perfusion. The lidocaine-phenylephrine combination used in this patient maximized haemodynamic stability and uteroplacental perfusion while giving adequate topical anaesthesia and vasoconstriction. This technique might also be applied to any patient requiting awake nasotraeheal intubation. 
